| Zheng, chao h |
NCT04146155: Efficacy and Safety of Liraglutide in Type 2 Diabetes With Lower Extremity Arterial Disease |
|
|
| Recruiting | 4 | 200 | RoW | Liraglutide+standard-of-care treatment, Victoza, standard-of-care treatment | Second Affiliated Hospital, School of Medicine, Zhejiang University | Type 2 Diabetes, Peripheral Vascular Disorder Due to Diabetes Mellitus | 12/21 | 12/21 | | |
HSK16149-207, NCT06490484: Efficacy and Safety of HSK16149 Capsule in Chinese Patients With Diabetic Peripheral Neuropathic Pain Who Had an Inadequate Response to Pregabalin |
|
|
| Recruiting | 2 | 90 | RoW | HSK16149 20mg BID, Crisugabalin, Pregabalin 150mg BID, Pregabalin | Haisco Pharmaceutical Group Co., Ltd. | Diabetic Peripheral Neuropathic Pain | 07/24 | 07/24 | | |
NCT06006689: Efficacy and Safety of QiShen YiQi Dripping Pills in the Treatment of Diabetic Kidney Disease (Syndrome of Qi Deficiency With Blood Stasis) |
|
|
| Recruiting | 2 | 228 | RoW | Qishen Yiqi Dripping Pills placebo 3 bags, Placebo group, Low dose Qishen Yiqi Dripping Pills 3 bags, Low dose group, High dose Qishen Yiqi Dripping Pills 3 bags, High dose group | Tasly Pharmaceutical Group Co., Ltd | Diabetic Kidney Disease | 09/25 | 09/25 | | |
NCT04931537: Screening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics. |
|
|
| Recruiting | N/A | 1000 | RoW | | Second Affiliated Hospital, School of Medicine, Zhejiang University, Second Affiliated Hospital of Wenzhou Medical University, Lishui Country People's Hospital | Diabetic Nephropathy Type 2, Biomarker | 12/23 | 12/28 | | |
| Zhang, Yikai |
NCT04931537: Screening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics. |
|
|
| Recruiting | N/A | 1000 | RoW | | Second Affiliated Hospital, School of Medicine, Zhejiang University, Second Affiliated Hospital of Wenzhou Medical University, Lishui Country People's Hospital | Diabetic Nephropathy Type 2, Biomarker | 12/23 | 12/28 | | |
